4-(3-(3-(trifluoromethyl)phenyl)-1H-pyrazol-4-yl)pyridine

ID: ALA4476705

PubChem CID: 3575503

Max Phase: Preclinical

Molecular Formula: C15H10F3N3

Molecular Weight: 289.26

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  FC(F)(F)c1cccc(-c2n[nH]cc2-c2ccncc2)c1

Standard InChI:  InChI=1S/C15H10F3N3/c16-15(17,18)12-3-1-2-11(8-12)14-13(9-20-21-14)10-4-6-19-7-5-10/h1-9H,(H,20,21)

Standard InChI Key:  UZOPNNYVHHABCA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
   15.0853  -15.4007    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5365  -14.7194    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0294  -14.0784    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2614  -14.3649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2996  -15.1803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6618  -15.6894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9009  -15.3883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2618  -15.8964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3824  -16.7055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1477  -17.0040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.7835  -16.4940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5815  -13.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6317  -13.1000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9506  -12.6499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2187  -13.0154    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.1722  -13.8355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8542  -14.2819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5015  -15.5966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3810  -14.7884    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.8618  -16.1051    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.6029  -15.2790    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  1  2  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
  5  6  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  4 12  1  0
  8 18  1  0
 18 19  1  0
 18 20  1  0
 18 21  1  0
M  END

Associated Targets(Human)

EPHX2 Tchem Epoxide hydratase (3844 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 289.26Molecular Weight (Monoisotopic): 289.0827AlogP: 4.16#Rotatable Bonds: 2
Polar Surface Area: 41.57Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.29CX LogP: 3.62CX LogD: 3.62
Aromatic Rings: 3Heavy Atoms: 21QED Weighted: 0.77Np Likeness Score: -1.59

References

1. Kotev M, Soliva R, Orozco M..  (2016)  Challenges of docking in large, flexible and promiscuous binding sites.,  24  (20): [PMID:27545443] [10.1016/j.bmc.2016.08.010]

Source